98 ABSTRACTBy replacing the antigen-binding domain, the present inventors discovered novel polypeptide complexes that retain BiTE's strong anti-tumor activity and excellent safety5 properties, as well as have long half-life in blood and can damage various different target cells.(No suitable figure)